Cargando…
Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1
Cannabidiol (CBD) is a non-psychoactive phytocannabinoid that has been discussed for its safety and efficacy in cancer treatments. For this reason, we have inquired into its use on triple-negative human breast cancer. Analyzing the biological effects of CBD on MDA-MB-231, we have demonstrated that b...
Autores principales: | D’Aloia, Alessia, Ceriani, Michela, Tisi, Renata, Stucchi, Simone, Sacco, Elena, Costa, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266539/ https://www.ncbi.nlm.nih.gov/pubmed/35806150 http://dx.doi.org/10.3390/ijms23137145 |
Ejemplares similares
-
Inhibition of IGF signalling pathway in MDA-MB-231 triple negative breast cancer cells
por: Chandran, S, et al.
Publicado: (2012) -
Identification of a Resistance Mechanism to IGF-IR Targeting in Human Triple Negative MDA-MB-231 Breast Cancer Cells
por: Tsui, Jennifer, et al.
Publicado: (2021) -
Characterization of Triple-Negative Breast Cancer MDA-MB-231 Cell Spheroid Model
por: Huang, Zhaoming, et al.
Publicado: (2020) -
MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative Breast Cancer MDA-MB-231 Cells
por: Pratelli, Giovanni, et al.
Publicado: (2023) -
PRIMA-1(MET) Does Not Restore Vitamin
D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast
Cancer Cells
por: Kotob, Shadi N., et al.
Publicado: (2023)